1. Home
  2. KLTO vs NCPL Comparison

KLTO vs NCPL Comparison

Compare KLTO & NCPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KLTO
  • NCPL
  • Stock Information
  • Founded
  • KLTO 2019
  • NCPL 1984
  • Country
  • KLTO United States
  • NCPL United States
  • Employees
  • KLTO N/A
  • NCPL N/A
  • Industry
  • KLTO
  • NCPL Investment Managers
  • Sector
  • KLTO
  • NCPL Finance
  • Exchange
  • KLTO NYSE
  • NCPL Nasdaq
  • Market Cap
  • KLTO 4.8M
  • NCPL 4.3M
  • IPO Year
  • KLTO N/A
  • NCPL N/A
  • Fundamental
  • Price
  • KLTO $0.22
  • NCPL $2.08
  • Analyst Decision
  • KLTO
  • NCPL
  • Analyst Count
  • KLTO 0
  • NCPL 0
  • Target Price
  • KLTO N/A
  • NCPL N/A
  • AVG Volume (30 Days)
  • KLTO 31.8M
  • NCPL 45.0K
  • Earning Date
  • KLTO 05-15-2025
  • NCPL 03-17-2025
  • Dividend Yield
  • KLTO N/A
  • NCPL N/A
  • EPS Growth
  • KLTO N/A
  • NCPL N/A
  • EPS
  • KLTO N/A
  • NCPL N/A
  • Revenue
  • KLTO N/A
  • NCPL $812,612.00
  • Revenue This Year
  • KLTO N/A
  • NCPL N/A
  • Revenue Next Year
  • KLTO N/A
  • NCPL $101.16
  • P/E Ratio
  • KLTO N/A
  • NCPL N/A
  • Revenue Growth
  • KLTO N/A
  • NCPL N/A
  • 52 Week Low
  • KLTO $0.11
  • NCPL $1.41
  • 52 Week High
  • KLTO $13.10
  • NCPL $22.82
  • Technical
  • Relative Strength Index (RSI)
  • KLTO N/A
  • NCPL 55.51
  • Support Level
  • KLTO N/A
  • NCPL $1.75
  • Resistance Level
  • KLTO N/A
  • NCPL $2.04
  • Average True Range (ATR)
  • KLTO 0.00
  • NCPL 0.09
  • MACD
  • KLTO 0.00
  • NCPL 0.00
  • Stochastic Oscillator
  • KLTO 0.00
  • NCPL 69.00

About KLTO KLOTHO NEUROSCIENCES INC

Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.

About NCPL Netcapital Inc.

Netcapital Inc is a financial technology company. The company facilitates the growth of private companies by providing fundraising services and other consulting services. The company's online private investment platform connects entrepreneurs and investors, enabling companies to raise capital digitally. The Company operates in a single operating segment, which is the provision of fintech services.

Share on Social Networks: